Strategies for induction of HIV‐1 envelope‐reactive broadly neutralizing antibodies
WB Williams, K Wiehe, KO Saunders… - Journal of the …, 2021 - Wiley Online Library
Introduction A primary focus of HIV‐1 vaccine development is the activation of B cell
receptors for naïve or precursor broadly neutralizing antibodies (bnAbs), followed by …
receptors for naïve or precursor broadly neutralizing antibodies (bnAbs), followed by …
Strategies for induction of HIV‐1 envelope‐reactive broadly neutralizing antibodies
WB Williams, K Wiehe, KO Saunders… - Journal of the …, 2021 - search.proquest.com
Discussion The recent Antibody Mediated Protection (AMP) trial that tested the protective
efficacy of one HIV‐1 Env bnAb specificity demonstrated that relatively high levels of long …
efficacy of one HIV‐1 Env bnAb specificity demonstrated that relatively high levels of long …
Strategies for induction of HIV-1 envelope-reactive broadly neutralizing antibodies.
WB Williams, K Wiehe, KO Saunders… - Journal of the …, 2021 - europepmc.org
Discussion The recent Antibody Mediated Protection (AMP) trial that tested the protective
efficacy of one HIV-1 Env bnAb specificity demonstrated that relatively high levels of long …
efficacy of one HIV-1 Env bnAb specificity demonstrated that relatively high levels of long …
Strategies for induction of HIV-1 envelope-reactive broadly neutralizing antibodies
WB Williams, K Wiehe… - Journal of the …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction A primary focus of HIV-1 vaccine development is the activation of B cell
receptors for naïve or precursor broadly neutralizing antibodies (bnAbs), followed by …
receptors for naïve or precursor broadly neutralizing antibodies (bnAbs), followed by …
Strategies for induction of HIV‐1 envelope‐reactive broadly neutralizing antibodies
WB Williams, K Wiehe, KO Saunders… - African Journal of …, 2021 - journals.lww.com
Introduction: A primary focus of HIV-1 vaccine development is the activation of B cell
receptors for naïve or precursor broadly neutralizing antibodies (bnAbs), followed by …
receptors for naïve or precursor broadly neutralizing antibodies (bnAbs), followed by …
[HTML][HTML] Strategies for induction of HIV‐1 envelope‐reactive broadly neutralizing antibodies
WB Williams, K Wiehe, KO Saunders… - Journal of the …, 2021 - ncbi.nlm.nih.gov
Discussion The recent Antibody Mediated Protection (AMP) trial that tested the protective
efficacy of one HIV‐1 Env bnAb specificity demonstrated that relatively high levels of long …
efficacy of one HIV‐1 Env bnAb specificity demonstrated that relatively high levels of long …
Strategies for induction of HIV-1 envelope-reactive broadly neutralizing antibodies.
WB Williams, K Wiehe, KO Saunders, BF Haynes - 2021 - cabidigitallibrary.org
Introduction: A primary focus of HIV-1 vaccine development is the activation of B cell
receptors for naïve or precursor broadly neutralizing antibodies (bnAbs), followed by …
receptors for naïve or precursor broadly neutralizing antibodies (bnAbs), followed by …